220 related articles for article (PubMed ID: 32041659)
1. Cathelicidin preserves intestinal barrier function in polymicrobial sepsis.
Ho J; Chan H; Liang Y; Liu X; Zhang L; Li Q; Zhang Y; Zeng J; Ugwu FN; Ho IHT; Hu W; Yau JCW; Wong SH; Wong WT; Ling L; Cho CH; Gallo RL; Gin T; Tse G; Yu J; Chan MTV; Leung CCH; Wu WKK
Crit Care; 2020 Feb; 24(1):47. PubMed ID: 32041659
[TBL] [Abstract][Full Text] [Related]
2. Effects of Different Routes and Forms of Vitamin D Administration on Mesenteric Lymph Node CD4+ T Cell Polarization and Intestinal Injury in Obese Mice Complicated with Polymicrobial Sepsis.
Yeh CL; Wu JM; Chen KY; Wu MH; Yang PJ; Lee PC; Chen PD; Yeh SL; Lin MT
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079813
[TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis.
Assimakopoulos SF; Papadopoulou I; Bantouna D; de Lastic AL; Rodi M; Mouzaki A; Gogos CA; Zolota V; Maroulis I
Shock; 2021 May; 55(5):666-675. PubMed ID: 32496421
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model.
Nagaoka I; Tamura H; Reich J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825174
[TBL] [Abstract][Full Text] [Related]
5. Cathelicidin-deficient mice exhibit increased survival and upregulation of key inflammatory response genes following cecal ligation and puncture.
Severino P; Ariga SK; Barbeiro HV; de Lima TM; de Paula Silva E; Barbeiro DF; Machado MCC; Nizet V; Pinheiro da Silva F
J Mol Med (Berl); 2017 Sep; 95(9):995-1003. PubMed ID: 28623379
[TBL] [Abstract][Full Text] [Related]
6. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils.
Kumagai Y; Murakami T; Kuwahara-Arai ; Iba T; Reich J; Nagaoka I
Innate Immun; 2020 Oct; 26(7):565-579. PubMed ID: 32600088
[TBL] [Abstract][Full Text] [Related]
8. Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice.
Tai EK; Wu WK; Wang XJ; Wong HP; Yu L; Li ZJ; Lee CW; Wong CC; Yu J; Sung JJ; Gallo RL; Cho CH
Gene Ther; 2013 Feb; 20(2):187-93. PubMed ID: 22378344
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice.
Hu Z; Murakami T; Suzuki K; Tamura H; Reich J; Kuwahara-Arai K; Iba T; Nagaoka I
Int Immunol; 2016 May; 28(5):245-53. PubMed ID: 26746575
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial peptide cathelicidin LL-37 preserves intestinal barrier and organ function in rats with heat stroke.
Shih CC; Liao WC; Ke HY; Kuo CW; Tsao CM; Tsai WC; Chiu YL; Huang HC; Wu CC
Biomed Pharmacother; 2023 May; 161():114565. PubMed ID: 36958193
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.
Fredenburgh LE; Velandia MM; Ma J; Olszak T; Cernadas M; Englert JA; Chung SW; Liu X; Begay C; Padera RF; Blumberg RS; Walsh SR; Baron RM; Perrella MA
J Immunol; 2011 Nov; 187(10):5255-67. PubMed ID: 21967897
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activity of vitamin D3 (VD3) does not result from VD3-induced antimicrobial agents including nitric oxide or cathelicidin.
Yamamoto K; Takahashi K; Ato M; Iwanaga S; Ohta N
Exp Parasitol; 2019 Jun; 201():67-77. PubMed ID: 30904694
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme-modified probiotic components protect rats against polymicrobial sepsis: role of macrophages and cathelicidin-related innate immunity.
Bu HF; Wang X; Zhu YQ; Williams RY; Hsueh W; Zheng X; Rozenfeld RA; Zuo XL; Tan XD
J Immunol; 2006 Dec; 177(12):8767-76. PubMed ID: 17142779
[TBL] [Abstract][Full Text] [Related]
14. Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.
Lorentz CA; Liang Z; Meng M; Chen CW; Yoseph BP; Breed ER; Mittal R; Klingensmith NJ; Farris AB; Burd EM; Koval M; Ford ML; Coopersmith CM
Mol Med; 2017 Aug; 23():155-165. PubMed ID: 28598488
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens.
Iimura M; Gallo RL; Hase K; Miyamoto Y; Eckmann L; Kagnoff MF
J Immunol; 2005 Apr; 174(8):4901-7. PubMed ID: 15814717
[TBL] [Abstract][Full Text] [Related]
16. Effects of intestinal alkaline phosphatase on intestinal barrier function in a cecal ligation and puncture (CLP)-induced mouse model for sepsis.
Plaeke P; De Man JG; Smet A; Malhotra-Kumar S; Pintelon I; Timmermans JP; Nullens S; Jorens PG; Hubens G; De Winter BY
Neurogastroenterol Motil; 2020 Mar; 32(3):e13754. PubMed ID: 31751495
[TBL] [Abstract][Full Text] [Related]
17. STING-mediated intestinal barrier dysfunction contributes to lethal sepsis.
Hu Q; Ren H; Li G; Wang D; Zhou Q; Wu J; Zheng J; Huang J; Slade DA; Wu X; Ren J
EBioMedicine; 2019 Mar; 41():497-508. PubMed ID: 30878597
[TBL] [Abstract][Full Text] [Related]
18. [Ulinastatin protects intestinal mucosal barrier by inhibiting the activation of intestinal NLRP3 inflammasomes in septic rats].
Li X; Yang C; Gulifeire T; Wang Y; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):192-197. PubMed ID: 33729139
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide Cathelicidin-BF prevents intestinal barrier dysfunction in a mouse model of endotoxemia.
Song D; Zong X; Zhang H; Wang T; Yi H; Luan C; Wang Y
Int Immunopharmacol; 2015 Mar; 25(1):141-7. PubMed ID: 25639228
[TBL] [Abstract][Full Text] [Related]
20. RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance.
Chen J; Purvis GSD; Collotta D; Al Zoubi S; Sugimoto MA; Cacace A; Martin L; Colas RA; Collino M; Dalli J; Thiemermann C
Front Immunol; 2020; 11():2080. PubMed ID: 32983159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
